A Phase 1, Open Label, Randomized, Single Dose, 5 Period Crossover Relative Bioavailability Study In Healthy Volunteers Evaluating Spray Dried Dispersion (SDD) Immediate Release (IR) PF-06273340 Tablet, Two SDD Modified Release (MR) Matrix Tablets In Comparison With PF-06273340 Oral Solution, Including Preliminary Assessment Of Food Effect
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2013
At a glance
- Drugs PF 6273340 (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 01 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Nov 2012 New trial record
- 01 Nov 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.